Clinical Trial Update: Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether 18F-FES PET imaging can influence therapeutic decisions for patients with metastatic breast cancer; the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FES (18F-fluoroestradiol)

Snippet

Sponsor: GE Healthcare | Conditions: Metastatic Breast Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING